WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: myesthenia gravis, myesthenia gravis treatment AChE inhibitor, 20 year old female patient 110 lbs is exhibiting symptoms of difficulty to chew & swallow (jaw gets tired), 20 year old female patient 110 lbs Daughter doesn't need vitamins her mother suggested Send to see a neurologist, Neuromuscular junctions complications may include Acetylcholine Receptor Antibodies, pyridostigmine (mestinon) con's check for cholinergic crisis, myesthenia gravis symptoms Cannot hold a firm handshake, myesthenia gravis symptoms difficulty talking, 20 year old female patient 110 lbs diagnostic testing 5 milligrams of initial Neostigmine intravenously, Neostigmine dose 0.5 mg/kg oral every 8 hours, myesthenia gravis is a disease where patients show decrease in muscle activity, Acetylcholine Receptor Antibodies which is responsible for 80% of myesthenia gravis, Ligand-gated Nicotinic Receptors found in Skeletal Muscle, a disease where patients show decrease in muscle activity caused by less acetylcholine binding to acetylcholine receptors, 20 year old female patient 110 lbs is exhibiting symptoms of weakness of eye muscles (patient had for 3 months), myesthenia gravis symptoms fatigue, myesthenia gravis symptoms drooping postion of head, mycophenolate time to clinical effect 2-6 months, Skeletal Muscle which is activated via Neuromuscular junctions, azathioprine time to clinical effect 3-18 months, pyridostigmine (mestinon) pro's inexpensive